Hansa Biopharma treats first commercial kidney transplant patient in Australia with Idefirix
Hansa Biopharma (HNSA) announces its first commercial kidney transplant patient treated with Idefirix in Australia.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.